U.S. Stock News

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...

Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for...

In the current U.S. market landscape, major stock indexes have experienced a pullback, with tech shares leading the decline despite some companies posting strong quarterly results. Amidst this backdrop of fluctuating indices and economic uncertainty, identifying growth companies with high insider ownership can be crucial for investors seeking potential resilience and alignment of interests between management and shareholders.

GoodRx Holdings announced that Trevor Bezdek, Co-Chairman of the Board, ended his employment and executive officer role as of November 1, 2025, and will stay on as a non-employee director; this coincides with the company's scheduled Q3 2025 earnings release on November 4. This combination of executive transition and earnings anticipation introduces new uncertainty about GoodRx's future leadership direction and financial outlook. We'll examine how the departure of an executive officer may...

Delcath Systems, Inc. recently announced its third quarter and nine-month financial results for 2025, revealing a net income of US$4.60 million for the nine-month period compared to a net loss of US$22.99 million a year earlier. This dramatic turnaround from a prior loss to a net profit may signal a shift in the company's operational trajectory and financial stability. We'll explore how Delcath's first nine-month net profit in years could reshape the investment narrative and expectations...

Rani Therapeutics Holdings announced it would present preclinical data on its RaniPill® oral delivery platform at ObesityWeek® 2025, highlighting that oral semaglutide (RT-116) in dogs is bioequivalent to subcutaneous injections and produces similar weight loss. This research could generate interest, as it demonstrates the potential for the RaniPill to enable oral delivery of peptide drugs traditionally administered via injection. We'll examine how these promising preclinical results for...

Pacific Biosciences of California (PACB) shares jumped after news broke that ARK Investment Management, led by Cathie Wood, had acquired over one million shares. This high-profile buy is increasing investor attention and speculation around PacBio’s DNA sequencing technology and its growth outlook. See our latest analysis for Pacific Biosciences of California. ARK’s sizeable buy-in comes as PacBio’s share price has staged a sharp reversal. After months of drifting, the past 30 days saw a...

Axcelis Technologies announced third quarter 2025 results showing revenue of US$213.61 million and diluted earnings per share of US$0.83, both declining from the prior year, and issued new fourth quarter guidance with expected revenue of around US$215 million and US$0.76 earnings per diluted share. This update highlights sustained business headwinds for Axcelis, with ongoing sequential declines in both revenue and profitability through year-end as reflected in their forward outlook. We'll...

Eastern Bankshares (EBC) is in the spotlight after HoldCo Asset Management publicly challenged its board to consider selling the company instead of pursuing more acquisitions. The move highlights shareholder concerns. See our latest analysis for Eastern Bankshares. The activist pressure arrives just as Eastern Bankshares’ share price shows signs of gathering momentum, with a strong 90-day share price return of nearly 13% despite some choppiness over the past month. Looking a bit further out,...

Middlesex Water (MSEX) shares have recently responded to third quarter earnings results that missed consensus expectations. Both revenue and earnings per share came in below forecasts amid softer water consumption. See our latest analysis for Middlesex Water. The disappointing third quarter results put immediate pressure on Middlesex Water’s share price, which slid more than 13% in a single day. While the company marked its 53rd consecutive dividend increase and announced a new utility...

We feel now is a pretty good time to analyse Blend Labs, Inc.'s ( NYSE:BLND ) business as it appears the company may be...

McGrath RentCorp recently reported its third-quarter 2025 earnings, revealing a year-over-year decline in sales and net income, and updated its full-year 2025 revenue guidance to a range of US$935 million to US$955 million. Institutional investor activity and the announcement of a quarterly dividend highlight continued shareholder engagement, even as profitability metrics from core operations moderated versus the prior year. We'll examine how McGrath RentCorp's updated guidance amid softer...

Unfortunately for some shareholders, the Cracker Barrel Old Country Store, Inc. ( NASDAQ:CBRL ) share price has dived...

Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...

Potential Western Alliance Bancorporation ( NYSE:WAL ) shareholders may wish to note that the Chief Financial Officer...

The GDEV Inc. ( NASDAQ:GDEV ) share price has softened a substantial 35% over the previous 30 days, handing back much...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Wondering if Dynatrace is a bargain or overpriced? If you have ever questioned whether now is the right time to invest, you are definitely not alone. After a string of ups and downs, Dynatrace’s share price is at $50.48. The stock is down 0.1% this week but up 1.8% over the last month, with year-to-date and one-year returns both dipping about -7%. Recent news has shaped the market’s mood, including Dynatrace’s announced enhancements to their AI capabilities, which could...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

Thinking about whether Arista Networks is a good value right now? You are not alone, as savvy investors are constantly asking themselves what the price tag really says about the company's future. Over the past year, Arista Networks' stock has soared 59.6% and is up a staggering 863.6% over the last five years, with recent momentum including a 0.5% climb in the last week and 8.3% over the past month. Part of this excitement comes from the company's ongoing advances in cloud networking,...

Freshpet (FRPT) delivered a notable performance with profit margins hitting 11.4%, up from 4.8% last year, and becoming profitable across the past five years with annual earnings growth averaging 41.8%. Most recently, the company's earnings climbed 180%, marking a sharp acceleration over earlier periods and highlighting a strong upswing in profitability. While forecasts point to continued revenue and earnings growth at 10% and 14% per year, respectively, both figures are set to trail just...

Innovex International (INVX) released its third quarter earnings, showing sales increased to $240 million from $152 million last year, while net income declined. The company also issued revenue guidance for the upcoming quarter. See our latest analysis for Innovex International. With Innovex International posting strong year-over-year sales growth but a dip in net income, the stock has attracted attention. Its share price is up 41% year-to-date, and the one-year total shareholder return...

If you have ever wondered whether Align Technology is an overlooked bargain or justifiably unloved, you are not alone. Let’s put the numbers under the microscope together. The stock recently climbed 2.1% over the past week and is up 4.8% over the last month. Despite these gains, Align Technology is still down more than 30% year to date, raising some big questions about future potential and risk perception. Investors have been reacting to industry developments and announcements around digital...

ON Semiconductor (ON) reported annual profit margins of 7.3%, down sharply from 24.8% a year ago, reflecting a major margin contraction driven by a one-off $634.2 million loss over the past twelve months. Looking ahead, analysts expect earnings to jump 38.99% per year, though revenue growth is forecast at a modest 4.7% annually, falling short of the broader US market’s 10.5% average. Despite these challenges, shares trade below the estimated fair value at $50.46 versus $59.80 and maintain a...